Selective Serotonin Reuptake Inhibitors and Suicide: Is the Evidence, as with Beauty, in the Eye of the Beholder?

Publisher： Karger

E-ISSN： 1423-0348|72|6|293-299

ISSN： 0033-3190

Source： Psychotherapy and Psychosomatics, Vol.72, Iss.6, 2003-10, pp. : 293-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Lines of Evidence on the Risks of Suicide with Selective Serotonin Reuptake Inhibitors

By  

Psychotherapy and Psychosomatics, Vol. 72, Iss. 2, 2003-03 ,pp. : 71-79

Karger

Access to resources Recommend Favorite

Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin‐Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta‐Analysis

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 5, 2015-05 ,pp. : 1002-1009

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs)

By Keene Matthew S.   Eaddy Michael T.   Mauch Robert P.   Regan Timothy S.   Shah Manan   Chiao Evelyn  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1651-1658

Informa Healthcare

Access to resources Recommend Favorite

The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors

By Wang Junling   White-Means Shelley I.   Hufstader Meghan A.   Walker Genene D.  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 853-863

Informa Healthcare

Access to resources Recommend Favorite

Should the Use of Selective Serotonin Reuptake Inhibitors in Child and Adolescent Depression Be Banned?

By  

Psychotherapy and Psychosomatics, Vol. 76, Iss. 1, 2006-12 ,pp. : 5-14

Karger

Access to resources Recommend Favorite